Media coverage ArchivesSelect Year2023-20242022-20239 July 2023 Wockhardt charting a recovery riding on a promising new antibiotic 14 June 2023 Successful Use of WCK 5222 in an Adult Patient with Acute T-Cell Leukemia 31 Mar 2023 Wockhardt Aims For $12m Annual Savings Through US Restructuring22 February, 202322 Feb 2023 Wockhardt to restructure US business to save $12 million per year, sees debt pare down22 February, 202322 Feb 2023 At a turning point. Wockhardt in talks for vaccine manufacture in the UK22 February, 202321 Feb 2023 A Game-Changer: India’s Under-Trial Drug Shows Promise Against Hospital Superbugs21 February, 202312 Feb 2023 Under-trial antibiotic use saves minor thalassemia patient’s life12 February, 202313 Nov 2022 Desi antibiotic under trial in Europe saves woman’s life13 November, 202213 Nov 2022 Under-trial antibiotic cleared superbug infection in 5 days13 November, 20225 Sep 2022 Wockhardt receives affirmation in credit ratings from CARE5 September, 202226 Aug 2022 Will restructuring US biz turnaround this pharma player?26 August, 202220 Aug 2022 Wockhardt ties up with various partners to roll out products in US market16 August, 202216 Aug 2022 Wockhardt initiates phase-III clinical study of new antibiotic candidate16 August, 2022
